Preclinical studies represent a key step in any drug development pipeline. They allow to evaluate pharmacological, toxicological and pharmaceutical properties of the molecule. Preclinical studies form a significant part of the registration dossier prepared for the State registration of the pharmaceutical product. Results of preclinical studies are filed with a protocol of clinical trials and draft instructions for use. On a basis of these results the researchers make a decision on the launch of Clinical Trial.
Please see below a list of preclinical study types performed by the labs of National BioService: